JENNIFER BARTON: Open Payments
NPI 1578967071 · WHITESBORO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 41 payments from 17 companies in 2025. Trend: 2023 $305 · 2024 $534 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $144 |
| PFIZER INC. | 5 | $106 |
| Novo Nordisk Inc | 5 | $89 |
| Collegium Pharmaceutical, Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Insulet Corporation | 1 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Abbott Laboratories | 2 | $38 |
| Lilly USA, LLC | 2 | $31 |
Products named: SHINGRIX, Jornay PM, PREVNAR 20, Auvelity, TRELEGY ELLIPTA, INJECTAFER, Omnipod, REXULTI.
Industry payments across NY — which companies pay providers there.
